Why Silicon Valley Keeps Losing to U.S. Healthcare

Over the past decade, Silicon Valley technology firms and Fortune 500 conglomerates have poured tens of billions of dollars into new healthcare models. Their strategy followed classic software disruption playbooks: build parallel systems outside legacy networks, scale rapidly, and force traditional incumbents to adapt.

The results have included corporate dissolutions, bankruptcy filings, and deep asset write-downs across joint ventures, retail clinics, artificial intelligence initiatives, and venture-backed digital health startups. The $4.5 trillion U.S. healthcare economy has consistently resisted external disruption, while its complex multi-payer ecosystem, regulatory mandates, and entrenched clinical workflows have forced corporate giants and technology investors to recalibrate.

Total U.S. healthcare spending reached $4.5 trillion in 2022, accounting for 17.3% of U.S. gross domestic product, according to the Centers for Medicare & Medicaid Services (CMS). That capital is divided among thousands of health plans, hospital networks, physician groups, and regulatory jurisdictions. Providers and software systems must interface with more than 10,000 commercial, Medicare Advantage, and Medicaid health plans, each with its own fee schedules, coverage criteria, and prior authorization rules.

Walmart’s retreat illustrated the difficulty of operating outside those established structures. In April 2024, the retail giant announced that it would close all 51 of its primary care and dental clinics across Georgia, Florida, Illinois, Missouri, and Texas, along with its virtual care service. Walmart launched the business in 2019 to provide low-cost, transparently priced care, but concluded that escalating operational costs and reimbursement pressures made the standalone clinic model unsustainable.

The same friction affected Haven, the non-profit joint venture launched in January 2018 by Amazon, Berkshire Hathaway, and JPMorgan Chase. Led by surgeon and author Dr. Atul Gawande, Haven was tasked with revamping health benefits and reducing costs for the companies’ combined 1.2 million employees. It struggled to navigate existing health insurance networks and pharmacy supply chains before disbanding in February 2021 after three years.

Healthcare’s legacy infrastructure also constrains scheduling. Industry access studies put the average wait for a physician appointment in major metropolitan areas at 31 days. Medical practices simultaneously lose between 20% and 30% of their daily appointment capacity to last-minute cancellations, patient no-shows, and fragmented scheduling systems that cannot dynamically fill vacant slots.

IBM pursued a different route through artificial intelligence. Formed in 2015 to revolutionize oncology and medical diagnostics, IBM Watson Health received roughly $4 billion in investment for health data analytics assets, including Truven Health Analytics and Merge Healthcare. Clinical pushback over Watson for Oncology’s recommendations and slow commercial adoption preceded IBM’s 2022 sale of most of the unit to private equity firm Francisco Partners for approximately $1 billion. The assets were subsequently rebranded as Merative.

Electronic Health Record (EHR) lock-in adds another barrier. Core patient data and clinical scheduling remain within entrenched legacy EHR vendors dominated by Epic Systems, Oracle Health, formerly Cerner, and Athenahealth. Their complex clinical workflows were designed around billing and regulatory compliance rather than rapid consumer booking.

Babylon Health, founded in the U.K., promised app-based, AI-driven primary care and triage. It went public in the U.S. through a Special Purpose Acquisition Company (SPAC) in October 2021 at a valuation exceeding $4 billion. By August 2023, Babylon’s U.S. operations had filed for Chapter 7 bankruptcy, while its original U.K. business was sold in a fire-sale transaction.

Other retrenchments followed. Amazon shut down its internal Amazon Care service in late 2022 and then shifted its strategy by acquiring established primary care provider 1Life Healthcare (One Medical) for $3.9 billion in early 2023. Pharmacy chain Walgreens Boots Alliance has also undertaken significant clinic closures within its VillageMD primary care unit to curtail operating losses.

Unlike software sectors that allow startups to build on clean-slate “greenfield” platforms, healthcare is a legacy “brownfield” environment. New technology entrants must work across fragmented insurance plans, established clinical systems, scheduling constraints, and regulatory requirements rather than simply replacing existing infrastructure.

Federal policy has encouraged integration with that infrastructure through the 21st Century Cures Act, enforced by the Office of the National Coordinator for Health Information Technology (ONC). The law mandates standardized Application Programming Interfaces (APIs), primarily using Fast Healthcare Interoperability Resources (FHIR) protocols, to facilitate secure data sharing across disparate platforms and penalize institutional “information blocking.”

Platforms that successfully scale in healthcare typically require massive backend integration efforts linking providers, insurers, and scheduling databases. Digital booking platform Zocdoc maintains direct calendar integrations with over 175 different EHR systems. Those connections enable real-time schedule synchronization across more than 200,000 providers in 200 specialties while filtering eligibility against thousands of insurance plans.

That operational plumbing requires navigating thousands of customized scheduling rules, administrative workflows, and regional compliance mandates. It is slower and more labor-intensive than launching consumer-facing apps, but seamless backend integration avoids creating isolated “walled gardens” that fail to achieve clinical scale.

generative AI has now brought another wave of technology investment into healthcare. Startups and technology leaders are introducing tools for clinical documentation, diagnostic imaging support, and automated revenue cycle management. Industry experts note that these advanced AI algorithms face the same adoption hurdles that stymied previous technological investments: without direct integration into existing clinical software, hospital credentialing, and insurance reimbursement frameworks, artificial intelligence risks exacerbating administrative friction rather than streamlining care delivery.

As major capital markets adjust to post-SPAC valuations and higher interest rates, health tech companies are increasingly being evaluated on whether they can integrate directly into established clinical environments, improve capacity utilization for existing physician practices, and work within standard reimbursement frameworks rather than bypassing the existing U.S. healthcare apparatus.